If AI 2027 is right, are we really going to make patients wait 15 years for treatments that will soon exist?
Summary
The article discusses how AI could dramatically accelerate biomedical research, creating a bottleneck where current clinical trial and regulatory processes may delay patient access to new treatments, calling for urgent adaptation to the pace of AI-driven discoveries.
Similar Articles
Will AI help speed up medical science?
A discussion on whether AI can accelerate medical science, potentially treating or curing chronic conditions in the coming decades, and whether a golden age of medicine is realistic.
AI is accelerating drug development
AI is transforming U.S. pharmaceutical R&D by accelerating drug discovery, preclinical testing, clinical trials, and regulatory review, with early evidence suggesting it could cut development times by roughly half and reduce costs.
@FinanceYF5: Is AI Really Accelerating Drug Development? According to McKinsey's latest research, some early signs have emerged: The…
McKinsey's latest research indicates that AI is accelerating drug development, with candidate drugs utilizing AI to shorten the discovery phase by 15% to 80%.
How is AI accelerating progress in medicine, and when will it reach the level of impact it has already achieved in programming and mathematics?
A discussion-style post asking how AI is currently accelerating medical research and development, and whether its impact in medicine will eventually match what it has achieved in programming and mathematics, or if breakthroughs beyond LLMs like world models and robotics are needed. The author is personally motivated to follow progress in the field due to their own health issues.
@gabriel1: billions of years of life will be lost from regulation in the coming 3 years since we'll solve most disease in the next…
A tech figure (@gabriel1) argues that AI will soon cure most diseases, and warns that slow regulatory approval could cost billions of years of life, urging regulators to staff up and speed up approvals.